PeptidePrices safety rating
7/10 · Not FDA-approved (Phase 2 trials)
47 vendors · 26 with an issuer-verified COA · lowest 10mg from $24.29 · checked
| Vendor | Price | Actions |
|---|---|---|
| 7-test panelVerified COAFreedom Diagnostics · Tested Aug 12, 2026 | $24.29 | Buy ARA-290 from Modern Research Peptides |
| $26.50 | Buy ARA-290 from Rocky Mountain Compounds | |
| 4-test panelVerified COAFreedom Diagnostics | $27.07 | Buy ARA-290 from PeakForce Labs |
| 5-test panelVerified COAKovera Labs · Tested Jun 2, 2026 | $30.00 | Buy ARA-290 from Ascension Peptides |
| $32.00 | Buy ARA-290 from Purus Peptides | |
| $35.00 | Buy ARA-290 from Essential Research Labs | |
| $35.10 | Buy ARA-290 from Noble Sciences | |
| 3-test panelVerified COAKovera Labs · Tested Jul 6, 2026 | $36.90 | Buy ARA-290 from Vector Amino Labs |
| 7-test panelVerified COAEthos Analytics · Tested Jul 27, 2026 | $37.12 | Buy ARA-290 from Glacier Aminos |
| 1-test panelVerified COAILS Laboratories | $37.49 | Buy ARA-290 from Amino Club |
| 4-test panelVerified COAFreedom Diagnostics · Tested Apr 3, 2026 | $38.69 | Buy ARA-290 from MS Peptides |
| 3-test panelVerified COAFreedom Diagnostics | $40.50 | Buy ARA-290 from Nationwide Peptides |
| $41.24 | Buy ARA-290 from Swift Peptides | |
| 4-test panelVerified COAFreedom Diagnostics · Tested Sep 9, 2025 | $42.49 | Buy ARA-290 from SomaChems |
| 3-test panelVerified COAJanoshik · Tested Jun 3, 2026 | $43.20 | Buy ARA-290 from Ameano Peptides |
| $43.20 | Buy ARA-290 from EZ Peptides | |
| 3-test panelVerified COAFreedom Diagnostics · Tested May 20, 2026 | $43.99 | Buy ARA-290 from Global Aminos |
| $44.99 | Buy ARA-290 from Arizen Bio Labs | |
| 2-test panelVerified COAJanoshik · Tested Jul 14, 2026 | $44.99 | Buy ARA-290 from ZestyRat Research |
| 4-test panelVerified COAILS Laboratories · Tested Jul 27, 2026 | $45.00 | Buy ARA-290 from American Amino & Peptides |
| 3-test panelVerified COAFreedom Diagnostics | $45.00 | Buy ARA-290 from Novaglo Research |
| $49.30 | Buy ARA-290 from Happy Peptides | |
| 6-test panelVerified COAILS Laboratories | $49.46 | Buy ARA-290 from Puratek Peptides |
| 3-test panelVerified COAFreedom Diagnostics · Tested Aug 17, 2026 | $49.50 | Buy ARA-290 from Great Northern Peptides |
| $50.22 | Buy ARA-290 from Atlas Longevity | |
| 4-test panelVerified COANorth American Diagnostics · Tested Jul 30, 2026 | $53.99 | Buy ARA-290 from PS Peptides |
| $54.00 | Buy ARA-290 from Eon Peptides | |
| 3-test panelVerified COAKovera Labs · Tested Aug 13, 2026 | $56.0010mg packageChecked today | Buy ARA-290 from Pure Peptides |
| 7-test panelVerified COAKovera Labs · Tested Jun 2, 2026 | $56.70 | Buy ARA-290 from Lost Coast Aminos |
| $59.0010mg packageChecked today | Buy ARA-290 from Alpha Carbon Labs | |
| $59.25 | Buy ARA-290 from Atomik Labz | |
| 6-test panelVerified COAFreedom Diagnostics · Tested Jul 15, 2026 | $59.49 | Buy ARA-290 from Orbitrex Peptides |
| 6-test panelVerified COAFreedom Diagnostics · Tested Jul 15, 2026 | $59.49 | Buy ARA-290 from Synthesis Peptides |
| 6-test panelVerified COABioSyn Systems · Tested Sep 8, 2026 | $59.99 | Buy ARA-290 from Cenexa Labs |
| $60.1410mg packageChecked today | Buy ARA-290 from Kensington Labs | |
| $61.19 | Buy ARA-290 from Summit Research Supply | |
| 3-test panelVerified COAJanoshik · Tested Jul 8, 2026 | $62.7910mg packageChecked today | Buy ARA-290 from Ultima Life |
| $64.9910mg packageChecked today | Buy ARA-290 from Cellugenix Peptides | |
| $67.49 | Buy ARA-290 from SKO Compounds | |
| $69.70 | Buy ARA-290 from HEEZ Research | |
| 4-test panelVerified COAILS Laboratories · Tested Aug 27, 2026 | $71.10 | Buy ARA-290 from BHG Labs |
| 2-test panelVerified COAHorizon Analytical · Tested Aug 6, 2026 | $71.9910mg packageChecked today | Buy ARA-290 from Northline Labs |
| $76.50 | Buy ARA-290 from Upgrade Bio Labs | |
| $79.20 | Buy ARA-290 from Dynotides | |
| $84.08 | Buy ARA-290 from Paramount Peptides | |
| $85.50 | Buy ARA-290 from BioLongevity Labs | |
| 2-test panelVerified COAOptima Labs | $92.2710mg packageChecked Sep 20 | Buy ARA-290 from Peptides Lab UK |
Tracked every day
The five cheapest in-stock package prices for ARA-290 on each collected day, and the vendors that most often held those places.
Five cheapest in-stock package prices per day
Listed package price before coupons, any vial size. This is not the coupon-adjusted lowest 10mg price used to rank the comparison.
Vendors most often in the cheapest five
Top 8 of 10 vendors that reached the cheapest five
Current market data
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for ARA-290 is $24.29 from Modern Research Peptides. The median across vendors is $49.50.
PeptidePrices found 51 in-stock listings from 47 vendors, checked through Oct 10, 2026. The lowest 10mg cost is 51% below the vendor median of $49.50; 23 vendors (49%) fall below that median. 47 of 47 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
7/10 · Not FDA-approved (Phase 2 trials)
Investigational non-erythropoietic EPO-derived peptide designed to activate the proposed innate repair receptor (IRR); early human studies examined anti-inflammatory and tissue-repair signaling.
Studied in small human trials for sarcoidosis-associated small-fiber neuropathy; type 2 diabetes with neuropathic symptoms; and diabetic macular edema.
Investigational; Phase 2 human trials
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Short human trials reported generally good tolerability, but long-term and uncommon risks remain unknown. One diabetes-trial participant stopped after worsening borderline renal insufficiency.
Small, short Phase 2 trials reported generally good tolerability; long-term and uncommon risks remain unknown Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Related pages